[Pharmacological and clinical study of the thrombolytic effectiveness of ocrase].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013552:Swine; D013923:Thromboembolism / Q000188:drug therapy
D005343:Fibrinolytic Agents; D010447:Peptide Hydrolases; C021901:ocrase
Farmakologicheskoe i klinicheskoe izuchenie tromboliticheskoĭ éffektivnosti okrazy.